Clinical significance of serum procalcitonin and presepsin in patients with acute cholangitis

Clinical significance of serum procalcitonin and presepsin in patients with acute cholangitis - Clinical significance of serum procalcitonin and presepsin in patients with acute cholangitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016437

Enrollment

Registered

2015-02-04

Start date

2015-02-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute cholangitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acute cholangitis Requirement for Emergent ERCP Ability to Obtain Written Informed Consent Good performance status (ECGOG : 0-2)

Exclusion criteria

Exclusion criteria: Inability to perform ERCP Inability to insertion of endoscopy Severe other organ failuer Inability to obtain informed consent

Design outcomes

Primary

Measure	Time frame
assessment of diagnostic ability and severity in patients with acute cholangitis	—

Secondary

Measure	Time frame
assessment of therapeutic efficacy in patients with acute cholangitis	—

Countries

Japan

Contacts

Public ContactMasayuki Kitano

Kinki University Faculty of Medicine Department of Gastroenterology and Hepatology

m-kitano@med.kindai.ac.jp072-366-0221

Outcome results